<DOC>
	<DOCNO>NCT00806975</DOCNO>
	<brief_summary>The purpose study investigate patient 's usability , preference blood glucose control new prefilled disposable insulin lispro mixture ( Humalog Mix 25 injection KwikPen® ) . For purpose , randomize open-label , 2-period direct comparative crossover study plan comparison insulin aspart mixture ( Novo Rapid 30 Mix injection FlexPen® ) .</brief_summary>
	<brief_title>Comparison Novo Rapid 30 Mix Injection FlexPen® Humalog 25 Mix Injection KwikPen® Type 2 Diabetic Patients</brief_title>
	<detailed_description>- Concomitant drug The treatment insulin preparation prohibit study period . As drug except insulin use treatment diabetes complication since time study , content change study principle unless complication cure . If new complication occur study period , appropriate treatment give judgment investigator . - Compliance treatment method The investigator give sufficient explanation follow content patient . - To inject prescribed volume insulin prescribe time . - To observe appoint date next visit . - Termination assessment The study discontinue follow event occurs start study . - Important protocol violation - When continue treatment judge difficult due onset adverse event - Death - When follow-up patient become impossible - Other , investigator judge necessary discontinue study</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Diabetes Complications</mesh_term>
	<mesh_term>Insulin Lispro</mesh_term>
	<criteria>Type 2 diabetes mellitus patient Patients use Humalog Mix 25 injection KwikPen® Novo Rapid 30 Mix injection FlexPen® 3 month . Outpatients regularly visit hospital Patients 20 year old old 80 year old ( gender disregard ) Patients serious complication heart , liver kidney Pregnant possibly pregnant patient , lactate patient Patients complicate malignant tumor present . Patients allergic insulin analog preparation . Patients take illegal drug . Patients participate clinical study . Other , patient judge inappropriate subject study investigator</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2008</verification_date>
</DOC>